ATTO/SOL
Attovia Therapeutics is a clinical-stage biopharmaceutical company developing next-generation biotherapeutics for immune-mediated diseases with high unmet need. Our lead pipeline candidates target commercially validated pathways and are designed through our ATTOBODY biologics platform to deliver improved treatments relative to the current standards of care. Leveraging our ATTOBODY platform, we have nominated three product candidates within our first two years, including one currently in the clinic, ATTO-1310. ATTO-1310 is an ATTOBODY-based therapeutic targeting interleukin-31 (IL-31) that completed dosing in a Phase 1 clinical trial in healthy volunteers (HVs) and patients in the first quarter of 2026.
Score | 22 |
|---|---|
24h Vol | $154.57 |
Liquidity | $1.7K |
Holders | N/A |
Audits | |
Age | 1 hour |
FDV | $2.1K |
Market Cap | $2.1K |
| Addresses | |
|---|---|
| Pool | |
| ATTO | |
| SOL |  |
| Developer |
ATTO to SOL Converter
Score | 22 |
|---|---|
24h Vol | $154.57 |
Liquidity | $1.7K |
Holders | N/A |
Audits | |
Age | 1 hour |
FDV | $2.1K |
Market Cap | $2.1K |
About Attovia Therapeutics, Inc (ATTO)
Attovia Therapeutics is a clinical-stage biopharmaceutical company developing next-generation biotherapeutics for immune-mediated diseases with high unmet need. Our lead pipeline candidates target commercially validated pathways and are designed through our ATTOBODY biologics platform to deliver improved treatments relative to the current standards of care. Leveraging our ATTOBODY platform, we have nominated three product candidates within our first two years, including one currently in the clinic, ATTO-1310. ATTO-1310 is an ATTOBODY-based therapeutic targeting interleukin-31 (IL-31) that completed dosing in a Phase 1 clinical trial in healthy volunteers (HVs) and patients in the first quarter of 2026.
Update Token InfoATTO/SOL Price Stats
The current price of ATTO (ATTO/SOL) on Pump.fun is $0.000002093, the price is up 1.48% in the last 24 hours. Its 24-hour trading volume is reported to be at $154.57 with a total of 18 transactions. ATTO/SOL contract address is DNYvm6q3F5fnnT2MtXF9m49V8z5GNN4shGBuHJyrdhxK, with a Fully Diluted Valuation (FDV) of $2,092.95 and a liquidity pool of $1,655.54.
